StockData
Processa Pharmaceuticals, Inc. logo

Processa Pharmaceuticals, Inc. (PCSA) stock

PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$1.73+0.01 (+0.58%)

Close on Nov 17, 2026Market cap $4.83MP/E –Yield –

Processa Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Processa Pharmaceuticals's revenue for the twelve months ending Sep 30, 2023 was $0. For fiscal 2022 it was $0. The highest annual figure on record is $312.48K in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2022Dec 31, 2022$0–
FY2021Dec 31, 2021$0-100.0%
FY2016Dec 31, 2016$5.00K-95.6%
FY2015Dec 31, 2015$113.43K+5.8%
FY2014Dec 31, 2014$107.24K-65.7%
FY2013Dec 31, 2013$312.48K+62.6%
FY2012Dec 31, 2012$192.15K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2023Sep 30, 2023$0–
Q2 FY2023Jun 30, 2023$0–
Q1 FY2023Mar 31, 2023$0–
Q4 FY2022Dec 31, 2022$0–
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$0–
Q1 FY2022Mar 31, 2022$0–
Q4 FY2021Dec 31, 2021$0–
Q3 FY2021Sep 30, 2021$0-100.0%
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–
Q2 FY2016Jun 30, 2016$0–
Q1 FY2016Mar 31, 2016$5.00K–

More Processa Pharmaceuticals figures

See a number that looks wrong?